Clinical guidelines for the diagnosis and treatment of lower urinary tract dysfunction in patients with spinal cord injury.


Journal

International journal of urology : official journal of the Japanese Urological Association
ISSN: 1442-2042
Titre abrégé: Int J Urol
Pays: Australia
ID NLM: 9440237

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 20 09 2019
accepted: 23 12 2019
pubmed: 23 2 2020
medline: 28 4 2021
entrez: 21 2 2020
Statut: ppublish

Résumé

The present article is an abridged English translation of the Japanese clinical guidelines for the diagnosis and treatment of lower urinary tract dysfunction in patients with spinal cord injury updated as of July 2019. The patients are adult spinal cord injured patients with lower urinary tract dysfunction; special consideration of pediatric and elderly populations is presented separately. The target audience is healthcare providers who are engaged in the medical care of patients with spinal cord injury. The mandatory assessment includes medical history, physical examination, frequency-volume chart, urinalysis, blood chemistry, transabdominal ultrasonography, measurement of post-void residual urine, uroflowmetry and video-urodynamic study. Optional assessments include questionnaires on the quality of life, renal scintigraphy and cystourethroscopy. The presence or absence of risk factors for renal damage and symptomatic urinary tract infection affects urinary management, as well as pharmacological treatments. Further treatment is recommended if the maximum conservative treatment fails to improve or prevent renal damage and symptomatic urinary tract infection. In addition, management of urinary incontinence should be considered individually in patients with risk factors for urinary incontinence and decreased quality of life.

Identifiants

pubmed: 32077161
doi: 10.1111/iju.14186
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

276-288

Informations de copyright

© 2020 The Japanese Urological Association.

Références

Kakizaki H, Igawa Y, Gotoh M, Takeda M, Hasegawa Y, Koyanagi T. Clinical practice guideline for lower urinary tract dysfunction in patients with chronic spinal cord injury (in Japanese). Blackwell Publishing, Tokyo, Japan, 2005.
Kimoto Y, Igawa Y, Ogawa T et al. Clinical practice guidelines for lower urinary tract dysfunction in patients with spinal cord injury (in Japanese). RichHill Medical Inc., Tokyo, Japan, 2011.
Gomelsky A, Lemack GE, Castano Botero JC et al. Current and future international patterns of care of neurogenic bladder after spinal cord injury. World J. Urol. 2018; 36: 1613-9.
Elliott S, Gomez R (eds). Urologic management of the spinal cord injured patient. A Joint SIU-ICUD International Consultation. SIU Academy, 2017.
Sakai H, Ueta T, Shiba K. Epidemiological survey of spinal cord injury in Fukuoka prefecture (in Japanese). Bone Joint Nerve 2011; 1: 475-80.
Tokioka T, Doi H, Komatsubara M, Inoue T. Epidemiological survey of traumatic spinal cord injury in Kochi (in Japanese). Nihon Sekizuishougai Igakukai Zasshi. 2014; 27: 158-9.
Kimoto Y, Ikeda S, Sengoku A et al. Japanese version of Qualiveen30 (in Japanese). Nihon Hainyokinou Gakkaishi 2014; 25: 290-7.
Yoshida M, Igawa Y, Higashimura S, Suzuki M, Niimi A, Sanada H. Translation and reliability and validity testing of a Japanese version of the Intermittent Self-Catheterization Questionnaire among disposable and reusable catheter users. Neurourol. Urodyn. 2017; 36: 1356-62.
Goto T, Kawasaki Y, Takemoto J, Abe Y, Namima T. Evaluating estimated glomerular filtration rates of creatinine and cystatin C for male patients with chronic spinal cord injury. Spinal Cord 2018; 56: 447-52.
Erlandsen EJ, Hansen RM, Randers E, Petersen LE, Abrahamsen J, Johannesen IL. Estimating the glomerular filtration rate using serum cystatin C levels in patients with spinal cord injuries. Spinal Cord 2012; 50: 778-83.
Kooshesh M, Safdarian M, Nikfallah A, Vaccaro AR, Rahimi-Movaghar V. Association between detrusor muscle function and level of the spinal cord injury. Cent. European J. Urol. 2018; 71: 92-7.
Schurch B, Iacovelli V, Averbeck MA, Carda S, Altaweel W, Finazzi Agrò E. Urodynamics in patients with spinal cord injury: A clinical review and best practice paper by a working group of The International Continence Society Urodynamics Committee. Neurourol. Urodyn. 2018; 37: 581-91.
Gilbert BR, Fulgham PF. Urinary tract imaging: basic principles of urologic ultrasonography. In: Wein JA, Kavoussi LR, Partin AW, Peters CA (eds). Campbell-Walsh Urology, 11th edn. Elsevier, Philadelphia, 2015; 63-84.
Deruyver Y, Hakim L, Frånken J, Ridder DD. The use of imaging techniques in understanding lower urinary tract (dys)function. Auton. Neurosc. 2016; 200: 11-2.
Ogawa T. Bladder deformities in patients with neurogenic bladder dysfunction. Urol. Int. 1991; 47(Suppl1): 59-62.
Tuna H, Cermik TF, Tuna F. Monitoring of renal function using 99mTc-DMSA and 99mTc-DTPA scintigraphy in patients with spinal cord injury. Rev. Esp. Med. Nucl. Imagen. Mol. 2012; 31: 322-7.
Pavese C, Schneider MP, Schubert M et al. Prediction of bladder outcomes after traumatic spinal cord injury: a longitudinal cohort study. PLoS Medicine 2016; 13: e1002041.
Elliott CS, Dallas KB, Zlatev D, Comiter CV, Crew J, Shem K. Volitional voiding of the bladder after spinal cord injury: Validation of bilateral lower extremity motor function as a key predictor. J. Urol. 2018; 200: 154-60.
Wyndaele JJ, Madersbacher H, Kovindha A. Conservative treatment of the neuropathic bladder in spinal cord injured patients. Spinal Cord 2011; 39: 294-300.
Blok B, Pannek J, Castro-Diaz D et al. EAU guideline on Neuro-Urology. [Cited 20 Aug 2018]. Available from URL: https://uroweb.org/wpcontent/uploads/EAU-Guidelines-on-Neuro-Urology-2018-large-text.pdf/
Romo PGB, Smith CP, Cox A et al. Non-surgical urologic management of neurogenic bladder after spinal cord injury. World J. Urol. 2018; 36: 1555-6.
Afsar SI, Yemisci OU, Cosar SN, Cetin N. Compliance with clean intermittent catheterization in spinal cord injury patients: a long-term follow-up study. Spinal Cord 2013; 51: 645-9.
Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J. Urol. 2000; 163: 768-72.
Singh R, Rohilla RK, Sangwan K, Siwach R, Magu NK, Sangwan SS. Bladder management methods and urological complications in spinal cord injury patients. Indian J. Orthop. 2011; 45: 141-7.
Togan T, Azap OK, Durukan E, Arslan H. The prevalence, etiologic agents and risk factors for urinary tract infection among spinal cord injury patients. Jundishapur J. Microbiol. 2014; 7: e8905.
Li L, Ye W, Ruan H, Yang B, Zhang S, Li L. Impact of hydrophilic catheters on urinary tract infections in people with spinal cord injury: systematic review and meta-analysis of randomized controlled trials. Arch. Phys. Med. Rehabil. 2013; 94: 782-7.
Chartier-Kastler E, Denys P. Intermittent catheterization with hydrophilic catheters as a treatment of chronic neurogenic urinary retention. Neurourol. Urodyn. 2011; 30: 21-31.
Bermingham SL, Hodgkinson S, Wright S, Hayter E, Spinks J, Pellowe C. Intermittent self catheterisation with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysis. BMJ 2013; 346: e8639.
Medical Advisory Secretariat. Hydrophilic catheters: an evidence-based analysis. Ont. Health Technol. Assess. Ser. 2006; 6: 1-31.
Koff SA, Gigax MR, Jayanthi VR. Nocturnal bladder emptying: a simple technique for reversing urinary tract deterioration in children with neurogenic bladder. J. Urol. 2005; 174: 1629-31.
Nguyen MT, Pavlock CL, Zderic SA, Carr MC, Canning DA. Overnight catheter drainage in children with poorly compliant bladders improves post-obstructive diuresis and urinary incontinence. J. Urol. 2005; 174: 1633-6.
Everaert K, Lumen N, Kerckhaert W, Willaert P, van Driel M. Urinary tract infections in spinal cord injury: prevention and treatment guidelines. Acta Clin. Belg. 2009; 64: 335-40.
Groen J, Pannek J, Castro Diaz D et al. Summary of European Association of Urology (EAU) guidelines on neuro-urology. Eur. Urol. 2016; 69: 324-33.
Sorokin I, De E. Options for independent bladder management in patients with spinal cord injury and hand function prohibiting intermittent catheterization. Neurourol. Urodyn. 2015; 34: 167-76.
English SF. Update on voiding dysfunction managed with suprapubic catheterization. Transl. Androl. Urol. 2017; 6(Suppl 2): S180-S185.
Niël-Weise BS, van den Broek PJ, da Silva EM, Silva LA. Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst Rev. 2012; (8): CD004201.
Hunter KF, Bharmal A, Moore KN. Long-term bladder drainage: Suprapubic catheter versus other methods: a scoping review. Neurourol. Urodyn. 2013; 32: 944-51.
Shepherd AJ, Mackay WG, Hagen S. Washout policies in long-term indwelling urinary catheterisation in adults. Cochrane Database Syst Rev. 2017; (3): CD004012.
Stothers L, Tsang B, Nigro M, Lazare D, Macnab A. An integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction. Spinal Cord 2016; 54: 1114-20.
Amarenco G, Sutory M, Zachoval R et al. Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study. Neurourol. Urodyn. 2017; 36: 414-21.
Krhut J, Borovička V, Bílková K et al. Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity: Prospective, randomized, double-blind, placebo-controlled study. Neurourol. Urodyn. 2018; 37: 2226-33.
Welk B, Hickling D, McKibbon M, Radomski S, Ethans K. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction. Neurourol. Urodyn. 2018; 37: 2810-7.
Yasuda K, Yamanishi T, Kawabe K, Ohshima H, Morita T. The effect of urapidil on neurogenic bladder: a placebo controlled double-blind study. J. Urol. 1996; 156: 1125-30.
Barendrecht MM, Oelke M, Laguma MP, Michel MC. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU. Int. 2007; 99: 749-52.
Cruz F, Herschorn S, Aliotta P et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomized, double-blind, placebo-controlled trial. Eur. Urol. 2011; 60: 742-50.
Ginsberg D, Gousse A, Keppenne V et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J. Urol. 2012; 187: 2131-9.
Karsenty G, Denys P, Amarenco G et al. Botulinum toxin A (Botox®) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur. Urol. 2008; 53: 275-87.
Mehta S, Hill D, McIntyre A et al. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury. Arch. Phys. Med. Rehabil. 2013; 94: 1473-81.
Biers SM, Venn SN, Greenwell TJ. The past, present and future of augmentation cystoplasty. BJU. Int. 2012; 109: 1280-93.
Shreck E, Gioia K, Lucioni A. Indications for augmentation cystoplasty in the era of onabotulinumtoxinA. Curr. Urol. Rep. 2016; 17: 27.
Hoen L, Ecclestone H, Blok BFM et al. Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: a systematic review. Neurourol. Urodyn. 2017; 36: 1685-702.
Myers JB, Mayer EN, Lenherr S; Neurogenic Bladder Research Group (NBRG.org). Management options for sphincteric deficiency in adults with neurogenic bladder. Transl. Androl. Urol. 2016; 5: 145-57.
Gor RA, Elliott SP. Surgical management of neurogenic lower urinary tract dysfunction. Urol. Clin. North Am. 2017; 44: 475-90.
Phé V, Boissier R, Blok BFM et al. Continent catheterizable tubes/stomas in adult neuro-urological patients: a systematic review. Neurourol. Urodyn. 2017; 36: 1711-22.
Stoffel JT. Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies. Transl. Androl. Urol. 2016; 5: 127-35.
Utomo E, Groen J, Blok BF. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction. Cochrane Database Syst. Rev. 2014; (5): CD004927.
Chancellor MB, Bennett C, Simoneau AR et al. Sphincteric stent versus external sphincterotomy in spinal cord injured men: prospective randomized multicenter trial. J. Urol 1999; 161: 1893-8.
Mehta SS, Tophill PR. Memokath stents for the treatment of detrusor sphincter dyssynergia (DSD) in men with spinal cord injury: the Princess Royal Spinal Injuries Unit 10-year experience. Spinal Cord 2006; 44: 1-6.
Kessler TM, Framboise DL, Trelle S et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: Systematic review and meta-analysis. Eur. Urol. 2010; 58: 865-74.
Wyndaele JJ, Birch B, Borau A et al. Sekido N. Surgical management of the neurogenic bladder after spinal cord injury. World J. Urol. 2018; 36: 1569-76.
Chen G, Liao L, Li Y. The possible role of percutaneous tibial nerve stimulation using adhesive skin surface electrodes in patients with neurogenic detrusor overactivity secondary to spinal cord injury. Int. Urol. Nephrol. 2015; 47: 451-55.
Ojha R, George J, Tharion G, Devasahayam SR. Neuromodulation by surface electrical stimulation of peripheral nerves for reduction of detrusor overactivity in patients with spinal cord injury: a pilot study. J. Spinal Cord Med. 2015; 38: 207-13.
Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological follow after spinal cord injury. J. Urol. 2012; 187: 391-7.
Sung BM, Oh DJ, Choi MH, Choi HM. Chronic kidney disease in neurogenic bladder. Nephrology 2018; 23: 231-6.
Averbeck MA, Madersbacher H. Follow-up of the neuro-urological patient: a systematic review. BJU. Int. 2015; 115: 36-46.
Kreydin E, Welk B, Chung D et al. Surveillance and management of urologic complications after spinal cord injury. World J. Urol. 2018; 36: 1545-53.
Gui-Zhong L, Li-Bo M. Bladder cancer in individuals with spinal cord injuries: a meta-analysis. Spinal Cord 2017; 55: 340-5.
D'Hondt F, Everaert K. Urinary tract infections in patients with spinal cord injuries. Curr. Infect. Dis. Rep. 2011; 13: 544-51.
Unsal-Delialioglu S, Kaya K, Sahin-Onat S, Kulakli F, Culha C, Ozel S. Fever during rehabilitation in patients with traumatic spinal cord injury: analysis of 392 cases from a national rehabilitation hospital in Turkey. J. Spinal Cord Med. 2010; 33: 243-8.
Vaidyanathan S, Hughes PL, Soni BM. A comparative study of ultrasound examination of urinary tract performed on spinal cord injury patients with no urinary symptoms and spinal cord injury patients with symptoms related to urinary tract: do findings of ultrasound examination lead to changes in clinical management? Sci. World J. 2006; 6: 2450-9.
Generao SE, Dall'era JP, Stone AR, Kurzrock EA. Spinal cord injury in children: long-term urodynamic and urological outcomes. J. Urol. 2004; 172: 1092-4.
Thompson C, Mutch J, Parent S, Mac-Thiong JM. The changing demographics of traumatic spinal cord injury: an 11-year study of 831 patients. J. Spinal Cord Med. 2015; 38: 214-23.
Chen Y, He Y, DeVivo MJ. Changing demographics and injury profile of new traumatic spinal cord injuries in the United States, 1972-2014. Arch. Phys. Med. Rehabil. 2016; 97: 1610-9.
Tokioka T, Tokuhiro A, Sugiyama H, Ikeda A, Sumita M, Tominaga T. Central cervical cord syndrome in Japan Spinal Cord Injury Database (in Japanese). Nihon Sekizuisyougai Igakukai Zasshi. 2007; 20: 84-5.
Schneider RC, Cherry G, Pantek H. Syndrome of acute central cervical cord injury; with special reference to mechanisms involved in hyperextension injuries of cervical spine. J. Neurosurg. 1954; 11: 546-77.
Smith CP, Kraus SR, Nickell KG, Boone TB. Video urodynamic findings in men with the central cord syndrome. J. Urol. 2000; 164: 2014-7.
Biering-Sørensen F, Biering-Sørensen T, Liu N, Malmqvist L, Wecht JM, Krassioukov A. Alterations in cardiac autonomic control in spinal cord injury. Auton. Neurosci. 2018; 209: 4-18.
Liu N, Zhou MW, Biering-Sørensen F, Krassioukov AV. Cardiovascular response during urodynamics in individuals with spinal cord injury. Spinal Cord 2017; 55: 279-84.
Shiroiwa T, Sung Y, Fukuda T, Lang H, Bae S, Tsutani K. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010; 19: 422-37.
Watanabe T, Yamamoto S, Gotoh M et al. Cost-effectiveness analysis of long-term intermittent self-catheterization with hydrophilic-coated and uncoated catheters in patients with spinal cord injury in Japan. Low. Urin. Tract Symptoms 2017; 9: 142-50.

Auteurs

Noritoshi Sekido (N)

Department of Urology, Toho University Ohashi Medical Center, Tokyo, Japan.

Yasuhiko Igawa (Y)

Department of Urology, Nagano Prefectural Shinshu Medical Center, Suzaka, Nagano, Japan.

Hidehiro Kakizaki (H)

Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.

Takeya Kitta (T)

Department of Renal and Genitourinary Surgery, Graduate School of Medical Science, Hokkaido University, Sapporo, Hokkaido, Japan.

Atsushi Sengoku (A)

Department of Urology, Hyogo Prefectural Rehabilitation Central Hospital, Kobe, Hyogo, Japan.

Satoru Takahashi (S)

Department of Urology, Nihon University School of Medicine, Tokyo, Japan.

Ryosuke Takahashi (R)

Department of Urology, Spinal Injuries Center, Iizuka, Fukuoka, Japan.

Katsuyuki Tanaka (K)

Department of Urology, Kanagawa Rehabilitation Hospital, Atsugi, Kanagawa, Japan.

Takashige Namima (T)

Department of Urology, Tohoku Rosai Hospital, Sendai, Miyagi, Japan.

Masashi Honda (M)

Division of Urology, Tottori University Faculty of Medicine, Yonago, Tottori, Japan.

Takahiko Mitsui (T)

Department of Urology, University of Yamanashi Graduate School of Medical Sciences, Chuo, Yamanashi, Japan.

Tomonori Yamanishi (T)

Department of Urology, Continence Center, Dokkyo Medical University, Mibu, Tochigi, Japan.

Toyohiko Watanabe (T)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH